Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001716
Filing Date
2009-03-13
Accepted
2009-03-13 12:35:31
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. FORM 10-K b73453epe10vk.htm 10-K 1095530
2 EX-10.9 INTELLECTUAL PROPERTY AGREEMENT b73453epexv10w9.htm EX-10.9 181987
3 EX-12.1 RATIO OF EARNINGS TO FIXED CHARGES b73453epexv12w1.htm EX-12.1 13320
4 EX-23.1 CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM b73453epexv23w1.htm EX-23.1 1508
5 EX-31.1 SECTION 302 CERTIFICATION OF ELKAN GAMZU, PH.D. b73453epexv31w1.htm EX-31.1 6205
6 EX-31.2 SECTION 302 CERTIFICATION OF KIM COBLEIGH DRAPKIN b73453epexv31w2.htm EX-31.2 6403
7 EX-32 SECTION 906 CERTIFICATION OF CEO AND CFO b73453epexv32.htm EX-32 4005
8 GRAPHIC b73453epb7345301.gif GRAPHIC 12177
  Complete submission text file 0000950135-09-001716.txt   1327330
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 781-761-7600
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21863 | Film No.: 09678737
SIC: 2834 Pharmaceutical Preparations